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The Foxp3+ T cell lineage is thought to arise from self-specific precursors during development. By
using a unique mouse model, Pacholczyk et al. (2007) present compelling evidence that self-specific
cells are exceedingly rare among Foxp3 and, surprisingly, Foxp3+ subsets.The critical roles of Foxp3+ regulatory
T (Treg) cells in dampening the poten-
tial catastrophic effects of unchecked
immune responses have been demon-
strated in numerous studies. Despite
intensive investigation, themechanism
of Foxp3+ Treg cell suppression still
remains largely unknown. A critical ob-
stacle to uncovering themechanism of
suppression has been a lack of knowl-
edge of the target antigens recognized
by the Foxp3+ lineage. Early studies
performed in models of autoimmunity
suggested that Treg cells are activated
by antigens derived from host tissues,
and the view that Foxp3+ Treg cells are
specific for self-antigens became a
well-entrenched dogma. One implica-
tion of such a model is that Treg cells
originated from precursor thymocytes
that received a unique instructive sig-
nal determined by the strength of T
cell receptor (TCR) engagement during
development. Signals stronger than
those required for positive selection
of conventional T (Tconv) cells, yet
below the threshold resulting in dele-
tion, have been hypothesized to lead
to the generation of Foxp3+ Treg cells.
This model of thymic selection of
Treg cells was bolstered by studies of
double-transgenicmice that expressed
a neoself-antigen along with the corre-
sponding high-affinity TCR specific for
antigen in the thymus (Jordan et al.,
2001). The proportion of suppressive
CD4+CD25+ T cells dramatically in-
creased relative to the conventional
CD4+CD25 subset. Importantly, an
increasewasnot seen inmice express-
ing a transgenic TCRwith a lower affin-
ity for the same antigen. Later studies
utilizing a neoself-antigen as a trans-gene under the control of a tetracy-
cline-regulated promoter (van Santen
et al., 2004) demonstrated that the
amount of the agonist could be corre-
lated with the development of antigen-
specific CD4+CD25+ T cells. Increas-
ing the expression of the agonist ligand
led to a corresponding increase in the
in the proportion of antigen-specific
CD4+CD25+ T cells. However, this
increase was not accompanied by
an increase in their absolute number,
but was secondary to a decrease
in the numbers of antigen-specific
CD4+CD25 T cells selected. These
results suggested that the Treg cell
lineage was potentially more resistant
to the effects of negative selection than
were their Tconv counterparts. As a
consequence, antigen-specific Treg
cells become overrepresented when
high amounts of the agonist peptide
were present because of the preferen-
tial loss of the antigen-specific Tconv
cells.
Although these studies provided
invaluable insight into possible mech-
anisms of Treg cell development, the
degree to which they truly represented
the natural process leading to the
selection of polyclonal Treg cells was
unclear. Attempting to measure the
diversity and specificity of polyclonal
T cells poses an extraordinary chal-
lenge because of the enormity of the
repertoire. Thus, comparisons of TCR
diversity at this level must employ
techniques that limit the repertoire to
amoremanageable size while simulta-
neously preserving a certain degree of
diversity. One study took this general
approach by analyzing TCR diversity
and the self-reactivity of the Treg andImmunity 27,Tconv cell subsets in mice expressing
a variable Va chain and a fixed trans-
genic TCR Vb-chain (Hsieh et al.,
2004). Direct sequencing of the TCRs
cloned from Treg and Tconv cells
from these mice demonstrated that
each possessed a comparable degree
of diversity. Although similarly diverse,
a comparison of the TCR sequences
present in each population suggested
that they expressed largely distinct
repertoires of receptors because only
20% of TCRs were shared between
them. Pacholczyk et al. (2006) also
concluded that the overlap between
the Treg and Tconv was modest, with
only 15%–20% of receptors shared,
but observed a greater degree of rep-
ertoire diversity within the Treg cell
subset than was reported by Hsieh
et al. (2004). These studies were con-
sistent with a model in which TCR
specificity determines the lineage fate
of the T cell.
The anergic phenotype of Treg cell
has been an important obstacle to
making determinations concerning
their specificity. To overcome this dif-
ficulty, Hsieh et al. (2006) cloned ten
TCRs that were unique to either
CD4+CD25+ or CD4+CD25 subsets
and re-expressed them in recombina-
tion-activating gene (RAG)-deficient
TCR transgenic CD4+ T cells by
retroviral transduction. The respective
pools of transduced T cells were then
transferred into lymphopenic hosts or
cocultured with autologous spleno-
cytes so that their respective expan-
sion abilities could be assessed. The
T cells that had been transduced with
receptors from CD4+CD25+, but not
CD4+CD25 T cells, conveyed anSeptember 2007 ª2007 Elsevier Inc. 417
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Previous attempts to compare TCR repertoires of Treg (blue bars) and Tconv (red bars) cells
focused exclusively on the most frequently found receptors (green shading) in each subset and
thus excluded large numbers of shared TCRs. Pacholczyk et al. (2007) have carried out a more
detailed analysis with a mouse that expresses a highly restricted but still polyclonal repertoire.
Analysis with this model permitted a much more complete picture of both repertoires to emerge
because TCRs present at very low frequencies in both subsets could now be studied (orange
shading).enhanced ability to expand, consistent
with a higher avidity for self-ligands.
One important caveat to these stud-
ies was that by focusing exclusively on
the most frequently used TCRs in each
group, both studies might have mark-
edly underestimated the degree of
repertoire overlap by excluding many
infrequently usedTCRs from their anal-
yses. With this in mind, Pacholczyk
et al. (2007) re-examined the reper-
toires of Treg and Tconv cell subsets,
employing a mouse model in which
the T cells express a single transgenic
TCRb chain and a variety of TCRa
chains derived from an unrearranged
TCRa minilocus. In contrast to their
previous work, the authors included
all TCRs present above a defined
threshold frequency (Figure 1). By in-
cluding these less frequent TCRs, a
substantial degree of overlap was
found in the two repertoires, although
the degree of usage of any particular
TCR varied considerably between the
subsets. This observation held true in
miceexpressingadiversearrayof pep-
tide-MHC class II complexes and in
mice whose MHC class II complexes
were exclusively occupied by a single
peptide. The finding of extensive over-
lap between the Treg and Tconv cell
repertoires argues against a model of418 Immunity 27, September 2007 ª2007Treg cell development in which the
specific TCR expressed dictates com-
mitment to the Foxp3+ lineage. These
data are also consistent with a recent
report that found a surprising degree
of repertoire overlap by using an analo-
gous model (Wong et al., 2007).
Pacholczyk et al. (2007) employed T
cell hybridoma technology to generate
large numbers of cells bearing recep-
tors derived from Treg cells. Because
these hybridomas lost the expression
of Foxp3, confirmation of their Treg
cell origin was accomplished by com-
paring hybridoma TCRsequenceswith
the database of Treg cell sequences
obtained from polymerase chain reac-
tion (PCR) products of single-cell-
sorted Foxp3+ T cells. In contrast to the
anergy exhibited by Treg cells, the hy-
bridomas secreted IL-2 in response
to TCR stimulation. Previous studies
demonstrated that the majority of T
cells selected in mice whose MHC
class II molecules are exclusively oc-
cupied with a single peptide react
with wild-type MHC class II molecules
of the same MHC haplotype because
these T cells have not been rendered
tolerant to the normal spectrum of
MHCclass II-peptidecomplexes found
in wild-type mice. Applying this logic,
Pacholczyk et al. (2007) comparedElsevier Inc.the reactivity of hybridomas derived
from Tconv and Treg cells selected in
TCR minilocus mice expressing sin-
gle-peptide-loaded MHC class II com-
plexes. A substantial portion of Treg
and Tconv cell-derived hybridomas
demonstrated reactivity toward wild-
type antigen-presenting cells (APCs)
displaying foreign peptides, whereas
none reacted with autologous APCs.
To exclude the possibility that abun-
dant expression of MHC class II com-
plexes loaded with a single peptide
led to the deletion of Treg cells bearing
self-specific receptors, the authors
also examined the self-reactivity of
Treg cell-derived hybridomas from
TCR minilocus and wild-type mice
selected on the normal array of MHC-
peptide complexes. In both cases,
none of the over 250 Treg hybridomas
tested reacted with MHC class II com-
plexes loaded with self-peptides. A
comparable frequency of Tconv and
Treg cell-derived hybridomas from
wild-type mice reacted with allogeneic
APCs, supporting the concept that
the specificities of the both repertoires
are biased toward nonself- rather than
self-MHC reactivity. In contrast to the
claim of Hsieh et al. (2004) that the
self-specificity of TCRs from Treg cells
resulted in wasting disease upon
transfer to lymphopenic recipients,
Pacholczyk et al. (2007) demonstrate
that nonself-antigens rather than self-
antigens are responsible for wasting
disease. Disease was only observed
when CD4+CD45hi T cells from TCRmini
or TCRmini mice expressing single-
peptide-MHC class II complexes were
transferred into lymphopenic animals
expressing wild-type peptide-MHC
class II complexes, but not into mice
that expressed single-peptide-MHC
class II complexes that lack the ability
to present exogenous antigens.
Although the results of Pacholczyk
et al. (2007) challenge the hypothesis
that Treg cell development in the thy-
mus is determined by the affinity of
their TCR for self, these data still do
not exclude the possibility for amoder-
ately enhanced avidity of Treg cell for
self-antigens unrelated to their TCR
repertoire. Two recent studies (Lin
et al., 2007; Gavin et al., 2007) provide
strong evidence that Foxp3 is not
responsible for the early development
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derived from mice with a disabled
Foxp3 gene express many, but not
all, of the phenotypic and functional
properties of normal Treg cells. Thus,
the signal(s) responsible for the initia-
tion of Treg cell development remains
unknown, and it remains possible
that one result of commitment to the
Treg cell lineage is an increased re-
sistance to negative selection in the
thymus resulting in a population of
Treg cells with a TCR repertoire similar
to Tconv cells but with slightly higher
affinity to self. The self-reactivity might
be below the threshold detectable
in a T cell hybridoma. Although the
studies of Pacholczyk et al. (2007) indi-
cate that the T cells that initiate wast-
ing disease recognize nonself, it is pre-
mature to conclude that the Treg cells
that protect from wasting disease also
exclusively recognize nonself. Self-
specific Treg cells might play a critical
early role in preventing disease by re-
acting to enhanced amounts of self-
peptide MHC class II and mediatingCrosspresentatio
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‘‘Exogenous antigens are loaded
onto major histocompatibility complex
(MHC) class II molecules, whereas en-
dogenous antigens are loaded onto
MHC class I molecules’’ is a golden
rule with notable exceptions. Pioneer-
ing work showed that antigen-specific
CD8+ T cells expand in vivowhen small
amounts of exogenous antigen are
delivered together with dead or dy-
ing cells, a phenomenon designatedbystander suppression. This model
does not exclude the possibility
that foreign antigen-specific Treg
cells play a complementary role in
protection.
Lastly, one must also consider the
implications of these studies of TCR
repertoire to vaccination. In contrast
to the well-described in vitro anergic
state of Foxp3+ Treg cells, they prolif-
erate and expand as efficiently as do
Tconv cells after in vivo priming. Be-
cause the TCR repertoires of Treg
and Tconv cells are certainly capable
of recognizing any foreign or patho-
gen-derived antigen, it is likely that
vaccination will result in proliferation
of both populations. Because the
marked proliferation of Treg cells in
the tumor-bearing host can be sec-
ondary to their higher affinity for tumor
(self-) antigens, tumor vaccines can re-
sult in further proliferation of the tumor-
specific Treg cells. Manipulation of the
balance between Treg and Tconv cells
in response to vaccination remains
a challenge for the future.n:
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ion are performed by specialized
w that human plasmacytoid d
to a lipopeptide or HIV-infected c
crosspriming or crosspresentation for
memory responses. A few years later,
several groups demonstrated that
a small fraction of dedicated dendritic
cells (DCs) within the DEC205+CD8a+
subset performs crosspriming (Bevan,
2006). Since then, the relevance of
crosspriming in immune responseshas
been the subject of extensive investi-
gation. Certainly, extending our knowl-
edge of the key players and molecular
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